Cardiac medication prescribing and adherence after acute myocardial infarction in Chinese and South Asian Canadian patients

BMC Cardiovascular Disorders

Nadia A Khan²  Kathryn M King¹  Hude Quan¹  Anita Palepu²  Maja Grubisic³  Emily J Lai² 

[1]Department of Community Health Sciences, University of Calgary, TRW Bldg 3rd floor - 3280 Hospital Dr NW, Calgary, AB T2N 4Z6, Canada

[2]Department of Medicine, University of British Columbia, 10th floor - 2775rel S Laut., Vancouver, BC V5Z 1M9, Canada

[3]Center for Health Evaluation and Outcomes Sciences, St. Paul's Hospital, 620B - 1081 Burrard St., Vancouver, BC V6Z 1Y6, Canada

关键词: ethnicity;    acute myocardial infarction;    medication adherence;   

Others  :  1085683
DOI  :  10.1186/1471-2261-11-56

 received in 2011-01-28, accepted in 2011-09-18,  发布年份 2011

【 摘 要 】

Background

Failure to adhere to cardiac medications after acute myocardial infarction (AMI) is associated with increased mortality. Language barriers and preference for traditional medications may predispose certain ethnic groups at high risk for non-adherence. We compared prescribing and adherence to ACE-inhibitors (ACEI), beta-blockers (BB), and statins following AMI among elderly Chinese, South Asian, and Non-Asian patients.

Methods

Retrospective-cohort study of elderly AMI survivors (1995-2002) using administrative data from British Columbia. AMI cases and ethnicity were identified using validated ICD-9/10 coding and surname algorithms, respectively. Medication adherence was assessed using the 'proportion of days covered' (PDC) metric with a PDC ≥ 0.80 indicating optimal adherence. The independent effect of ethnicity on adherence was assessed using multivariable modeling, adjusting for socio-demographic and clinical characteristics.

Results

There were 9926 elderly AMI survivors (258 Chinese, 511 South Asian patients). More Chinese patients were prescribed BBs (79.7% vs. 73.1%, p = 0.04) and more South Asian patients were prescribed statins (73.5% vs. 65.2%, p = 0.001). Both Chinese (Odds Ratio [OR] 0.53; 95%CI, 0.39-0.73; p < 0.0001) and South Asian (OR 0.78; 95%CI, 0.61-0.99; p = 0.04) patients were less adherent to ACEI compared to Non-Asian patients. South Asian patients were more adherent to BBs (OR 1.3; 95%CI, 1.04-1.62; p = 0.02). There was no difference in prescribing of ACEI, nor adherence to statins among the ethnicities.

Conclusion

Despite a higher likelihood of being prescribed evidence-based therapies following AMI, Chinese and South Asian patients were less likely to adhere to ACEI compared to their Non-Asian counterparts.

【 授权许可】

   
2011 Lai et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]First International Study of Infarct Survival collaborative group: Randomized trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986, 2:57-66.
• [2]Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000, 342:145-53.
• [3]Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002, 360:7-22.
• [4]Sackett DL, Snow JC: The magnitude of adherence and nonadherence. In Compliance in Health Care. Edited by Haynes RB, Taylor DW, Sackett DL. Baltimore: Johns Hopkins University Press; 1979:11-22.
• [5]Sabate E: Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
• [6]Rasmussen JN, Chong A, Alter DA: Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007, 297:177-86.
• [7]Berg JS, Dischler J, Wagner DJ, Raia JJ, Palmer-Shevlin N: Medication compliance: a healthcare problem. Ann Pharmacother 1993, 27(suppl 9):S1-24.
• [8]Rodgers PT, Ruffin DM: Medication nonadherence - Part I: The health and humanistic consequences. Manag Care Interface 1998, 11:58-60.
• [9]Rodgers PT, Ruffin DM: Medication nonadherence - Part II: a pilot study in patients with congestive heart failure. Manag Care Interface 1998, 11:67-9. 75
• [10]Osterberg L, Blaschke T: Adherence to medication. N Engl J Med 2005, 353:487-97.
• [11]Francis CK: Hypertension, cardiac disease, and compliance in minority patients. Am J Med 1991, 91:1A.29S-36S.
• [12]Charles H, Good C, Hanusa BH, Chang CH, Whittle J: Racial differences in adherence to cardiac medications. J Natl Med Assoc 2003, 95:17-22.
• [13]Bosworth HB, Dudley T, Olsen MK, Voils CI, Powers B, Goldstein MK, Oddone EZ: Racial differences in blood pressure control: potential explanatory factors. Am J Med 2006, 119:70.e9-15.
• [14]Siegel D, Lopez J, Meier J: Antihypertensive medication adherence in the Department of Veterans Affairs. Am J Med 2007, 120:26-32.
• [15]McDowell SE, Coleman JJ, Ferner RE: Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ 2006, 332:1177-81.
• [16]Freemantle N, Cleland J, Young P, Mason J, Harrison J: β blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999, 318:1730-7.
• [17]The Scandinavian Simvastatin Survival Study group: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). Lancet 1994, 344:1383-9.
• [18]Ryan TJ, Antman EL, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Reigel BJ, Russell RO, Smith III EE, Weaver WD: 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1999, 34:890-911.
• [19]Braunwald E, Antman EL, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith III EE, Steward DE, Theroux P: ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 2002, 40:1366-74.
• [20]Levy AR, O'Brien BJ, Sellors C, Grootendorst P, Willison D: Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol 2003, 10:67-71.
• [21]Quan J, Parson G, Ghali W: Validity of information on comorbidity derived from ICD-9-CM administrative data. Medical care 2002, 40:675-85.
• [22]Tu JV, Austin PC, Naylor CD, Iron K, Zhang H: Acute myocardial infarction outcomes in Ontario. In Cardiovascular health and services in Ontario: An ICES atlas. Edited by Naylor CD, Slaughter PM. Toronto, Ontario: Institute for Clinical Evaluative Sciences; 1999:83-110.
• [23]Vermeulen MJ, Tu JV, Schull MJ: ICD-10 adaptations of the Ontario acute myocardial infarction mortality prediction rules performed as well as the original versions. J Clin Epidemiol 2007, 60:971-4.
• [24]Masi R: Multiculturalism, medicine and health Part I: Multicultural health care. Can Fam Physician 1988, 2173-2178.
• [25]Waxler-Morrison N, Anderson J, Richardson E: Cross-cultural caring. A handbook for health professionals in Western Canada. Vancouver, BC: University of British Columbia Press; 1990.
• [26]Statistics Canada 2001 Census of Canada [http:/ / www12.statcan.ca/ english/ census01/ products/ analytic/ companion/ etoimm/ canada.cfm#threefold_increase] webcite
• [27]Quan H, Wang F, Schopflocher D, Norris C, Galbraith PD, Faris P, Graham MM, Knudtson ML, Ghali WA: Development and validation of a surname list to define Chinese ethnicity. Medical Care 2006, 44:328-33.
• [28]Harding S, Dew H, Simpson SL: The potential to identify South Asians using a computerized algorithm to classify names. Popul Trends 1999, 97:46-9.
• [29]Cummins C, Winter H, Cheng KK, Maric R, Silcocks P, Varghese C: An assessment of the Nam Pehchan computer program for the identification of names of south Asian ethnic origin. J Public Health Med 1999, 21:401-6.
• [30]Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J: Long-term persistence in use of statin therapy in elderly patients. JAMA 2002, 288:455-61.
• [31]Balkrishnan R: Predictors of medication adherence in the elderly. Clin Ther 1998, 20:764-71.
• [32]Ammassari A, Trotta MP, Murri R, Castelli F, Narciso P, Noto P, Vecchiet J, Monforte A, Wu AW, Antinori A: Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr 2002, 31(suppl 3):S123-7.
• [33]Schroeder K, Fahey T, Ebrahim S: Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database of systematic reviews 2004, (3):CD004804.
• [34]Tu JV, Austin PC, Walld R, Roos L, Agras J, McDonald KM: Development and validation of the Ontario acute myocardial infarction mortality prediction rules. J Am Coll Cardiol 2001, 37:992-7.
• [35]Gislason GH, Rasmussen JN, Abildstrom SZ, Gadsboll N, Buch P, Friberg J, Rasmussen S, Kober L, Stender S, Madsen M, Torp-Pedersen C: Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J 2006, 27:1153-8.
• [36]Britton A, Shipley M, Marmot M, Hemingway H: Does access to cardiac investigation and treatment contribute to social and ethnic differences in coronary heart disease? Whitehall II prospective cohort study. BMJ 2004, 329:318-23.
• [37]Lopez-Quintero C, Berry EM, Neumark Y: Limited English proficiency is a barrier to receipt of advice about physical activity and diet among Hispanics with chronic diseases in the United States. J Am Diet Assoc 2009, 109:1769-74.
• [38]King KM, LeBlanc P, Sanguins J, Mather C: Gender-based challenges faced by older Sikh women as immigrants: recognizing and acting on the risk of coronary artery disease. Can J Nurs Res 2006, 38:16-40.
• [39]King KM, LeBlanc P, Carr W, Quan H: Chinese immigrants' management of their cardiovascular disease risk. West J Nurs Res 2007, 29:804-26.
• [40]King KM, Mather CD, Sanguins J: Ethnocultural affiliation, gender, and cardiovascular disease risk management. Can J Cardiovasc Nurs 2005, 15:10-6.
• [41]Washington G, Wang-Letzkus MF: Self-care practices, health beliefs, and attitudes of older diabetic Chinese Americans. J Health Hum Serv Adm 2009, 32:305-23.
• [42]Lindesay J, Jagger C, Hibbett MJ, Peet SM, Moledina F: Knowledge, uptake and availability of health and social services among Asian Gujarati and white elderly persons. Ethn Health 1997, 2:59-69.
• [43]Pieroni A, Sheikh QZ, Ali W, Torry B: Traditional medicines used by Pakistani migrants from Mirpur living in Bradford, Northern England. Complement Ther Med 2008, 16:81-6.
• [44]Odegard PS, Gray SL: Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ 2008, 34:692-7.
• [45]Krousel-Wood MA, Muntner P, Joyce CJ, Islam T, Stanley E, Holt EW, Morisky DE, He J, Webber LS: Adverse effects of complementary and alternative medicine on antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc 2010, 58:54-61.
• [46]Li WW, Froelicher ES: Gender differences in Chinese immigrants: predictors for antihypertensive medication adherence. J Transcult Nurs 2007, 18:331-8.
• [47]Li WW, Stotts NA, Froelicher ES: Compliance with antihypertensive medication in Chinese immigrants: cultural specific issues and theoretical application. Res Theory Nurs Pract 2007, 21:236-54.
• [48]Health Canada safety information for rosuvastatin (Crestor) [http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/_2005/2005_10-eng.php] webcite
• [49]Lau HS, de Boer A, Beuning KS, Porsius A: Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 1997, 50:619-625.
• [50]Steiner JF, Prochazka AV: The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997, 50:105-16.
• [51]West SL, Savitz DA, Koch G, Strom BL, Guess HA, Hartzema A: Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 1995, 142:1104-12.